C69.50 - Malignant neoplasm of unspecified lacrimal gland and duct
| ICD-10: | C69.50 |
| Short Description: | Malignant neoplasm of unspecified lacrimal gland and duct |
| Long Description: | Malignant neoplasm of unspecified lacrimal gland and duct |
| Status: | Valid for Submission |
| Version: | ICD-10-CM 2023 |
| Code Classification: |
C69.50 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of unspecified lacrimal gland and duct. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following anatomical sites found in the Table of Neoplasms reference the parent code C69.5 of the current diagnosis code given the correct histological behavior: Neoplasm, neoplastic lacrimal ; Neoplasm, neoplastic lacrimal canaliculi ; Neoplasm, neoplastic lacrimal duct (nasal) ; Neoplasm, neoplastic lacrimal gland ; Neoplasm, neoplastic lacrimal punctum ; Neoplasm, neoplastic lacrimal sac ; Neoplasm, neoplastic nasolacrimal duct ; etc
Unspecified diagnosis codes like C69.50 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Adenocarcinoma of lacrimal gland
- Adenoid cystic carcinoma of lacrimal gland
- Carcinoma ex pleomorphic adenoma of lacrimal gland
- Lacrimal caruncle finding
- Lump in caruncle of eye
- Malignant melanoma of lacrimal drainage system
- Malignant melanoma of lacrimal gland
- Malignant neoplasm of canthus
- Malignant neoplasm of lacrimal sac
- Malignant neoplasm of nasolacrimal duct
- Malignant tumor of lacrimal drainage structure
- Malignant tumor of lacrimal gland
- Mucoepidermoid tumor of lacrimal gland
- Neoplasm of nasolacrimal duct
- Primary adenocarcinoma of lacrimal apparatus
- Primary adenocarcinoma of lacrimal gland
- Primary malignant neoplasm of conjunctiva of eye
- Primary malignant neoplasm of lacrimal apparatus
- Primary malignant neoplasm of lacrimal caruncle
- Primary malignant neoplasm of lacrimal drainage system
- Primary malignant neoplasm of lacrimal gland
- Primary malignant neoplasm of lacrimal gland duct
- Primary mucoepidermoid carcinoma of lacrimal apparatus
- Primary squamous cell carcinoma of lacrimal apparatus
Convert to ICD-9 Code
| Source ICD-10 Code | Target ICD-9 Code | |
|---|---|---|
| C69.50 | 190.2 - Mal neo lacrimal gland | |
| Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code. | ||
| C69.50 | 190.7 - Mal neo lacrimal duct | |
| Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code. | ||
Table of Neoplasms
The parent code C69.5 of the current diagnosis code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
| Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
|---|---|---|---|---|---|---|
| »Neoplasm, neoplastic »lacrimal | C69.5 | C79.49 | D09.2 | D31.5 | D48.7 | D49.89 |
| »Neoplasm, neoplastic »lacrimal »canaliculi | C69.5 | C79.49 | D09.2 | D31.5 | D48.7 | D49.89 |
| »Neoplasm, neoplastic »lacrimal »duct (nasal) | C69.5 | C79.49 | D09.2 | D31.5 | D48.7 | D49.89 |
| »Neoplasm, neoplastic »lacrimal »gland | C69.5 | C79.49 | D09.2 | D31.5 | D48.7 | D49.89 |
| »Neoplasm, neoplastic »lacrimal »punctum | C69.5 | C79.49 | D09.2 | D31.5 | D48.7 | D49.89 |
| »Neoplasm, neoplastic »lacrimal »sac | C69.5 | C79.49 | D09.2 | D31.5 | D48.7 | D49.89 |
| »Neoplasm, neoplastic »nasolacrimal duct | C69.5 | C79.49 | D09.2 | D31.5 | D48.7 | D49.89 |
Patient Education
Eye Cancer
Cancer of the eye is uncommon. It can affect the outer parts of the eye, such as the eyelid, which are made up of muscles, skin and nerves. If the cancer starts inside the eyeball it's called intraocular cancer. The most common intraocular cancers in adults are melanoma and lymphoma. The most common eye cancer in children is retinoblastoma, which starts in the cells of the retina. Cancer can also spread to the eye from other parts of the body.
Treatment for eye cancer varies by the type and by how advanced it is. It may include surgery, radiation therapy, freezing or heat therapy, or laser therapy.
[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)